ASSOCIATION OF PULMONARY HYPERTENSION WITH OUTCOMES IN PATIENTS WITH SYSTEMIC SCLEROSIS AND OTHER CONNECTIVE TISSUE DISORDERS: REVIEW AND META-ANALYSIS

被引:1
|
作者
Gegenava, Maka [1 ]
Gegenava, Tea [2 ]
机构
[1] Tbilisi State Med Univ, Dept Internal Med 2, GE-2023 Tbilisi, Georgia
[2] Tbilisi State Med Univ, Dept Internal Med 1, Tbilisi, Georgia
关键词
Pulmonary hypertension; Systemic Sclerosis; Systemic lupus erythematosus; ARTERIAL-HYPERTENSION; PREVALENCE; SURVIVAL;
D O I
10.36141/svdld.v41i1.14570
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and aim: Pulmonary hypertension (PH) is a frequent complication of connective tissue disorders (CTDs), with a major impact on the prognosis of the disease. The aim of our study was to perform a systemic review and meta -analysis of published literature evaluating survival function in patients with systemic sclerosis (SSc) with and without PH and to compare survival function between patients with SSc, systemic lupus erythematosus (SLE), other CTDs, and conditions associated with PH. Methods: The established protocol of the Cochrane Collaboration Steps and meta -analysis of observational studies in epidemiology recommendations (MOOSE) were used. Results: 7 studies, including 1470 SSc-PH patients and 1368 SSc patients without PH, and 4 studies, including 108 SLE-PH patients and 1288 SLE patients without PH, assessed survival function were selected. Six studies (including 777 SSc, 249 SLE, 90 idiopathic pulmonary arterial hypertension -IPAH (2 papers selected for the study with the old terminology of idiopathic pulmonary hypertension-IPH and idiopathic primary pulmonary hypertension IPP) and 29 primary Sjogren's syndrome patients) comparing survival function in different subgroups of patients with confirmed PH were included. SSc patients with PH showed the worst survival as compared to SSc patients without PH [OR (95% CI) 3.70 (2.42-5.67); p<0.00001]. The same pattern was observed in patients with SLE. SSc patients with PH were characterized by lower survival function compared to other reasons for PH, including SLE [OR (95% CI) 2.76 (1.95-3.91); p<0.00001]. Conclusions: Patients with SSc-PH are characterized by significantly lower survival function as compared to SSc patients without PH. Among the different entities of PH, SSc shows the worst survival, underlining prognostic significance of detection and evaluation of PH according to the currently established approach.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis
    Budhram, Brandon
    Weatherald, Jason
    Humbert, Marc
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 419 - 434
  • [2] Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis
    Xiong, Anji
    Liu, Qingting
    Zhong, Jiaxun
    Cao, Yuzi
    Xiang, Qilang
    Hu, Ziyi
    Zhou, Shifeng
    Song, Zhuoyao
    Chen, Huini
    Zhang, Yan
    Cui, Hongxu
    Shuai, Shiquan
    ADVANCES IN RHEUMATOLOGY, 2022, 62 (01)
  • [3] Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis
    Erdogan, Mustafa
    Esatoglu, Sinem Nihal
    Avci, Burcak Kilickiran
    Hatemi, Gulen
    INTERNAL AND EMERGENCY MEDICINE, 2024, 19 (03) : 731 - 743
  • [4] Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease
    Niklas, Karolina
    Niklas, Arkadiusz
    Mularek-Kubzdela, Tatiana
    Puszczewicz, Mariusz
    MEDICINE, 2018, 97 (28)
  • [5] Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis
    Mustafa Erdogan
    Sinem Nihal Esatoglu
    Burcak Kilickiran Avci
    Gulen Hatemi
    Internal and Emergency Medicine, 2024, 19 : 731 - 743
  • [6] Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis
    Lewis, Christopher
    Sanderson, Ryan
    Vasilottos, Nektarios
    Zheutlin, Alexander
    Visovatti, Scott
    HEART FAILURE CLINICS, 2023, 19 (01) : 45 - 54
  • [7] The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysis
    Rubio-Rivas, Manuel
    Homs, Narcis A.
    Cuartero, Daniel
    Corbella, Xavier
    AUTOIMMUNITY REVIEWS, 2021, 20 (01)
  • [8] Thyroid disorders in patients with systemic sclerosis: A systematic review and meta-analysis
    Yao, Qiuming
    Song, Zhenyu
    Wang, Bin
    Zhang, Jin-an
    Mu, Kaida
    AUTOIMMUNITY REVIEWS, 2019, 18 (06) : 634 - 636
  • [9] Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes
    Brown, Zoe
    Proudman, Susanna
    Morrisroe, Kathleen
    Stevens, Wendy
    Hansen, Dylan
    Nikpour, Mandana
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2021, 51 (03) : 495 - 512
  • [10] Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis
    Anji Xiong
    Qingting Liu
    Jiaxun Zhong
    Yuzi Cao
    Qilang Xiang
    Ziyi Hu
    Shifeng Zhou
    Zhuoyao Song
    Huini Chen
    Yan Zhang
    Hongxu Cui
    Shiquan Shuai
    Advances in Rheumatology, 62